IMDX
Insight Molecular Diagnostics Inc.
3.50$
+2.4%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | 152.5% | 35.4% | 101.9% | 72.5% | 60.7% | 95.3% | |
| – | – | – | – | – | – | – | -52.5% | 64.6% | -1.9% | 27.5% | 39.3% | 4.7% | |
| – | – | – | – | – | – | – | 805.9% | 229.1% | 762.1% | 618.4% | 523.1% | 392.1% | |
| – | – | – | – | – | – | – | 1,380.6% | 927.5% | 2,245.9% | 863.5% | 698.8% | 262.2% | |
| – | – | – | – | – | – | – | 2,390.8% | 2,508.9% | 1,876.7% | 1,699.9% | 3,284.5% | 758.8% | |
| – | – | – | – | – | – | – | -2,443.3% | -2,444.3% | -1,878.6% | -1,672.4% | -3,245.1% | -754.1% | |
| – | – | – | – | – | – | – | 20.7% | 9.5% | 8.7% | 3.5% | 4.5% | 2.7% | |
| – | – | – | – | – | – | – | -2,564.6% | -2,405.4% | -1,942.8% | -1,653.7% | -3,225.0% | -1,238.5% | |
| – | – | – | – | – | – | – | -103.1% | -421.3% | 5,723.2% | – | – | – | |
| – | – | – | – | – | – | – | -2,461.5% | -2,916.2% | -7,609.8% | -1,848.4% | -3,225.0% | -1,238.5% | |
| – | – | – | – | – | – | – | -2,511.5% | -2,204.6% | -1,389.2% | -1,538.5% | -3,137.4% | -1,181.7% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.